Ischemic Cerebral Stroke Prevention Therapeutics Market: Opportunities and Forecast Assessment, 2017 - 2027
Future Market Insights has announced the addition of the “Ischemic Cerebral Stroke Prevention Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
Future Market Insights has announced the addition of the “Ischemic Cerebral Stroke Prevention Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
<strong>Ischemic</strong> <strong>Cerebral</strong> <strong>Stroke</strong> <strong>Prevention</strong> <strong>Therapeutics</strong>: Key Players<br />
Key players operating in the global intravenous ultrasound systems market are Johnson & Johnson<br />
(Cordis Corporation), Boston <strong>Therapeutics</strong>, Inc., Edge <strong>Therapeutics</strong>, Inc., Zocere, Inc., Lundbeck,<br />
ThromboGenics, Vernalis, Bayer, Bristol-Myers Squibb, <strong>and</strong> Boehringer Ingelheim.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 9
Change language